Report Detail
Global Belzutifan Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4706228 |
- 09 June, 2026 |
- Global |
- 80 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Belzutifan market size was valued at US$ 720 million in 2025 and is forecast to a readjusted size of US$ 1637 million by 2032 with a CAGR of 10.0% during review period.
In 2025, global Belzutifan production reached approximately 42,000 units.Belzutifan is an orally administered small-molecule hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor used for the treatment of tumor diseases associated with abnormalities in the hypoxia signaling pathway. The drug selectively inhibits HIF-2α transcriptional activity, thereby reducing the expression of downstream pro-tumor genes, such as those involved in angiogenesis and cell proliferation, ultimately suppressing tumor growth and slowing disease progression. Belzutifan is primarily indicated for the treatment of von Hippel-Lindau (VHL) disease-associated tumors and advanced renal cell carcinoma (RCC), and it represents an important emerging innovative therapy targeting tumor metabolism and hypoxia pathways.
Belzutifan, as the first approved HIF-2α inhibitor, is positioned in the early high-growth stage of the emerging targeted oncology therapy market. It is primarily used in the treatment of von Hippel-Lindau (VHL) disease-associated tumors and advanced renal cell carcinoma (RCC). In recent years, with the advancement of precision oncology and the further elucidation of the role of hypoxia signaling pathways in tumorigenesis, the HIF-2α target has become an important direction for next-generation anticancer drug development. Against this backdrop, Belzutifan has established a first-mover advantage in the market due to its innovative mechanism and demonstrated efficacy in VHL-associated tumors. However, the field is still in an early stage of commercialization, with a relatively limited patient population and an incompletely realized market potential. At the same time, it faces competitive pressure from VEGF inhibitors and immunotherapy-based combination regimens. Therefore, its future market growth will largely depend on indication expansion, development of combination therapies, and increased penetration in larger indications such as renal cell carcinoma.
This report is a detailed and comprehensive analysis for global Belzutifan market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Belzutifan market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Belzutifan market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Belzutifan market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Belzutifan market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Belzutifan
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Belzutifan market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co, Peloton Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Belzutifan market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
40 mg tablets
120 mg tablets
Market segment by Sales Channels
Hospital
Retail
Online
Market segment by Combination Therapy
With VEGF Inhibitors in Combination Therapy
With Immune Checkpoint Inhibitors in Combination Therapy
Market segment by Production Technology
Originator
Generic
Market segment by Application
Von Hippel-Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC)
Von Hippel-Lindau (VHL) Disease-Associated Central Nervous System Hemangioblastomas
Von Hippel-Lindau (VHL) Disease-Associated Pancreatic Neuroendocrine Tumors (pNET)
Pheochromocytoma and Paraganglioma (PPGL) Associated with VHL Disease
Otherts
Major players covered
Merck & Co
Peloton Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Belzutifan product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Belzutifan, with price, sales quantity, revenue, and global market share of Belzutifan from 2021 to 2026.
Chapter 3, the Belzutifan competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Belzutifan breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Belzutifan market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Belzutifan.
Chapter 14 and 15, to describe Belzutifan sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Belzutifan Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 40 mg tablets
- 1.3.3 120 mg tablets
- 1.4 Market Analysis by Sales Channels
- 1.4.1 Overview: Global Belzutifan Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Retail
- 1.4.4 Online
- 1.5 Market Analysis by Combination Therapy
- 1.5.1 Overview: Global Belzutifan Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
- 1.5.2 With VEGF Inhibitors in Combination Therapy
- 1.5.3 With Immune Checkpoint Inhibitors in Combination Therapy
- 1.6 Market Analysis by Production Technology
- 1.6.1 Overview: Global Belzutifan Consumption Value by Production Technology: 2021 Versus 2025 Versus 2032
- 1.6.2 Originator
- 1.6.3 Generic
- 1.7 Market Analysis by Application
- 1.7.1 Overview: Global Belzutifan Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 Von Hippel-Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC)
- 1.7.3 Von Hippel-Lindau (VHL) Disease-Associated Central Nervous System Hemangioblastomas
- 1.7.4 Von Hippel-Lindau (VHL) Disease-Associated Pancreatic Neuroendocrine Tumors (pNET)
- 1.7.5 Pheochromocytoma and Paraganglioma (PPGL) Associated with VHL Disease
- 1.7.6 Otherts
- 1.8 Global Belzutifan Market Size & Forecast
- 1.8.1 Global Belzutifan Consumption Value (2021 & 2025 & 2032)
- 1.8.2 Global Belzutifan Sales Quantity (2021-2032)
- 1.8.3 Global Belzutifan Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Merck & Co
- 2.1.1 Merck & Co Details
- 2.1.2 Merck & Co Major Business
- 2.1.3 Merck & Co Belzutifan Product and Services
- 2.1.4 Merck & Co Belzutifan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Merck & Co Recent Developments/Updates
- 2.2 Peloton Therapeutics
- 2.2.1 Peloton Therapeutics Details
- 2.2.2 Peloton Therapeutics Major Business
- 2.2.3 Peloton Therapeutics Belzutifan Product and Services
- 2.2.4 Peloton Therapeutics Belzutifan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Peloton Therapeutics Recent Developments/Updates
3 Competitive Environment: Belzutifan by Manufacturer
- 3.1 Global Belzutifan Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Belzutifan Revenue by Manufacturer (2021-2026)
- 3.3 Global Belzutifan Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Belzutifan by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Belzutifan Manufacturer Market Share in 2025
- 3.4.3 Top 6 Belzutifan Manufacturer Market Share in 2025
- 3.5 Belzutifan Market: Overall Company Footprint Analysis
- 3.5.1 Belzutifan Market: Region Footprint
- 3.5.2 Belzutifan Market: Company Product Type Footprint
- 3.5.3 Belzutifan Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Belzutifan Market Size by Region
- 4.1.1 Global Belzutifan Sales Quantity by Region (2021-2032)
- 4.1.2 Global Belzutifan Consumption Value by Region (2021-2032)
- 4.1.3 Global Belzutifan Average Price by Region (2021-2032)
- 4.2 North America Belzutifan Consumption Value (2021-2032)
- 4.3 Europe Belzutifan Consumption Value (2021-2032)
- 4.4 Asia-Pacific Belzutifan Consumption Value (2021-2032)
- 4.5 South America Belzutifan Consumption Value (2021-2032)
- 4.6 Middle East & Africa Belzutifan Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Belzutifan Sales Quantity by Type (2021-2032)
- 5.2 Global Belzutifan Consumption Value by Type (2021-2032)
- 5.3 Global Belzutifan Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Belzutifan Sales Quantity by Application (2021-2032)
- 6.2 Global Belzutifan Consumption Value by Application (2021-2032)
- 6.3 Global Belzutifan Average Price by Application (2021-2032)
7 North America
- 7.1 North America Belzutifan Sales Quantity by Type (2021-2032)
- 7.2 North America Belzutifan Sales Quantity by Application (2021-2032)
- 7.3 North America Belzutifan Market Size by Country
- 7.3.1 North America Belzutifan Sales Quantity by Country (2021-2032)
- 7.3.2 North America Belzutifan Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Belzutifan Sales Quantity by Type (2021-2032)
- 8.2 Europe Belzutifan Sales Quantity by Application (2021-2032)
- 8.3 Europe Belzutifan Market Size by Country
- 8.3.1 Europe Belzutifan Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Belzutifan Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Belzutifan Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Belzutifan Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Belzutifan Market Size by Region
- 9.3.1 Asia-Pacific Belzutifan Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Belzutifan Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Belzutifan Sales Quantity by Type (2021-2032)
- 10.2 South America Belzutifan Sales Quantity by Application (2021-2032)
- 10.3 South America Belzutifan Market Size by Country
- 10.3.1 South America Belzutifan Sales Quantity by Country (2021-2032)
- 10.3.2 South America Belzutifan Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Belzutifan Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Belzutifan Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Belzutifan Market Size by Country
- 11.3.1 Middle East & Africa Belzutifan Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Belzutifan Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Belzutifan Market Drivers
- 12.2 Belzutifan Market Restraints
- 12.3 Belzutifan Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Belzutifan and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Belzutifan
- 13.3 Belzutifan Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Belzutifan Typical Distributors
- 14.3 Belzutifan Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Belzutifan. Industry analysis & Market Report on Belzutifan is a syndicated market report, published as Global Belzutifan Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Belzutifan market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
